Ambrisentan: a guide to its use in pulmonary arterial hypertension

被引:0
|
作者
机构
关键词
D O I
10.2165/0042310-200925070-00001
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 5
页数:4
相关论文
共 50 条
  • [41] Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension
    Zhuang, Yugang
    Jiang, Bojie
    Gao, Hui
    Zhao, Wei
    HYPERTENSION RESEARCH, 2014, 37 (06) : 507 - 512
  • [42] Efficacy, safety, and pharmacokinetics of ambrisentan in Japanese adults with pulmonary arterial hypertension
    Yoshida, Shunji
    Shirato, Kunio
    Shimamura, Ryutaro
    Nakahara, Norie
    Iwase, Takayuki
    Nakajima, Hiromu
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (09) : 1827 - 1834
  • [43] Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension
    Yugang Zhuang
    Bojie Jiang
    Hui Gao
    Wei Zhao
    Hypertension Research, 2014, 37 : 507 - 512
  • [44] Sildenafil - A review of its use in pulmonary arterial hypertension
    Croom, Katherine F.
    Curran, Monique P.
    DRUGS, 2008, 68 (03) : 383 - 397
  • [45] SildenafilA Review of its Use in Pulmonary Arterial Hypertension
    Katherine F. Croom
    Monique P. Curran
    Drugs, 2008, 68 : 383 - 397
  • [46] Ambrisentan for the treatment of pulmonary arterial hypertension -: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
    Galie, Nazzareno
    Olschewski, Horst
    Oudiz, Ronald J.
    Torres, Fernando
    Frost, Adaani
    Ghofrani, Hossein A.
    Badesch, David B.
    McGoon, Michael D.
    McLaughlin, Vallerie V.
    Roecker, Ellen B.
    Gerber, Michael J.
    Dufton, Christopher
    Wiens, Brian L.
    Rubin, Lewis J.
    CIRCULATION, 2008, 117 (23) : 3010 - 3019
  • [47] Clinical Safety, Pharmacokinetics, and Efficacy of Ambrisentan Therapy in Children With Pulmonary Arterial Hypertension
    Takatsuki, Shinichi
    Rosenzweig, Erika B.
    Zuckerman, Warren
    Brady, Daniela
    Calderbank, Michelle
    Ivy, D. Dunbar
    PEDIATRIC PULMONOLOGY, 2013, 48 (01) : 27 - 34
  • [48] Ambrisentan for the treatment of pulmonary arterial hypertension: a budget impact analysis in the Italian context
    Barbieri, Marco
    Zamboni, William
    Pippo, Lara
    Madaan, Prateek
    Campana, Carlo
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (10): : 989 - 997
  • [49] Edema in Patient Switched to Macitentan from Bosentan and Ambrisentan in Pulmonary Arterial Hypertension
    Safdar, Zeenat
    Thakur, Aishwarya
    Frost, Adaani
    CHEST, 2015, 148 (04)
  • [50] Long-Term Ambrisentan Therapy for Pulmonary Arterial Hypertension: Comparison by Etiology
    Pulido, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179